Eric Halioua, President & CEO of PDC*line Pharma will make a company presentation at the inaugural Meeting on the Mediterranean in Barcelona (Spain) April 23-25. ? Don’t forget to step by and meet him...
- PDC*line Pharma grants exclusive license in South Korea and exclusive option in other Asian countries to LG Chem Life Sciences Company, for the development and commercialization of PDC*lung cancer...
Eric Halioua, President & CEO of PDC*line Pharma will present the company at the World Immunotherapy Congress USA 2019 taking place March 4th, in the Grand Hyatt, San Diego (USA). ? Don’t forget to...
PDC*line Pharma is GMP accredited by the Belgian Federal Agency for Medicines and Health Products (FAMHP) for its Quality Control and Release Activities for PDC*lung, a drug for lung cancer...
Eric Halioua, President & CEO of PDC*line Pharma will be spaker in the Cell & Gene Therapy Innovation Leaders Summit organized, 6th - 7th Feb 2019 at Movenpick Hotel Potsdamer Platz Berlin (Germany)...
#JPM2019- The PDC*line Pharma management team will be present in full force in San Francisco during the JP Morgan Conference 2019!
Meet our CEO Eric Halioua, our CSO Joel Plumas and our COO Laurent...
Eric Halioua, President & CEO of PDC*line Pharma will be a panelist at Sachs Forum 2018, Basel.
Eric Halioua, President & CEO of PDC*line Pharma will present the company at Bio€quity Europe, May 14 – 16, 2018 in Ghent, Belgium. Flanders.bio’s flagship event knowledge for growth will be organized...
PDC*line Pharma CEO and COO will be in Amsterdam (The Netherlands), March 12–14, 2018 for the BIO-EUROPE SPRING 12th annual international partnering conference. Contact us for a face to face meeting...
Eric Halioua, President & CEO of PDC*line Pharma will present the company at the 11th Annual European Life Sciences CEO Forum. A Sachs Associates event organized, Feb. 26, 2018 in Hilton Zurich...
